Wu Wenjun
#5,795
Most Influential Person Now
Chinese mathematician
Wu Wenjun's AcademicInfluence.com Rankings
Wu Wenjunmathematics Degrees
Mathematics
#446
World Rank
#886
Historical Rank
Measure Theory
#4575
World Rank
#5355
Historical Rank
Download Badge
Mathematics
Wu Wenjun's Degrees
- PhD Mathematics Université Paris Cité
Why Is Wu Wenjun Influential?
(Suggest an Edit or Addition)According to Wikipedia, Wu Wenjun , also commonly known as Wu Wen-tsün, was a Chinese mathematician, historian, and writer. He was an academician at the Chinese Academy of Sciences , best known for Wu class, Wu formula, and Wu's method of characteristic set.
Wu Wenjun's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma (2017) (73)
- Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Predicting the Adverse Effects of Chimeric Antigen Receptor T Cell Therapy in Patients with Non-Hodgkin Lymphoma. (2019) (57)
- Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models. (2015) (52)
- Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study (2019) (44)
- Basic principles of mechanical theorem proving in elementary geometries (1986) (33)
- A zero structure theorem for polynomial-equations-solving and its applications (1987) (31)
- A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia (2018) (30)
- CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study (2018) (27)
- Quercetin induces cell apoptosis of myeloma and displays a synergistic effect with dexamethasone in vitro and in vivo xenograft models (2016) (26)
- Single cell transcriptomic analysis reveals BCMA CAR-T cell dynamics in a patient with refractory primary plasma cell leukemia. (2020) (23)
- Camalexin Induces Apoptosis via the ROS-ER Stress-Mitochondrial Apoptosis Pathway in AML Cells (2018) (23)
- Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells (2017) (21)
- A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia (2020) (20)
- New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (2021) (19)
- ON THE FOUNDATION OF ALGEBRAIC DIFFERENTIAL GEOMETRY (2008) (18)
- Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells (2018) (18)
- Mechanical theorem proving of differential geometries and some of its applications in mechanics (1991) (18)
- Fibroblast activation protein protects bortezomib-induced apoptosis in multiple myeloma cells through β-catenin signaling pathway (2014) (16)
- CD19/CD22 Dual-Targeted CAR T-cell Therapy for Relapsed/Refractory Aggressive B-cell Lymphoma: A Safety and Efficacy Study (2021) (16)
- BAFF is involved in macrophage-induced bortezomib resistance in myeloma (2017) (15)
- The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma (2013) (15)
- Polynomial Equations-Solving and its Applications (1994) (15)
- Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy (2021) (13)
- Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy (2019) (13)
- Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience. (2009) (13)
- Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway (2017) (13)
- Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies (2020) (12)
- Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma (2021) (12)
- Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies (2019) (12)
- Primary splenic diffuse large B-cell lymphoma in a patient with thymus Rosai-Dorfman disease. (2012) (12)
- On the Product of Sphere Bundles and the Duality Theorem Modulo Two (1948) (11)
- Vernodalol enhances TRAIL‐induced apoptosis in diffuse large B‐cell lymphoma cells (2017) (10)
- Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data (2020) (10)
- Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis (2019) (10)
- Successful chimeric antigen receptor T cells therapy in extramedullary relapses of acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation (2019) (10)
- Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway (2018) (10)
- Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma (2021) (10)
- Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy (2018) (9)
- On Chern numbers of algebraic varieties with arbitrary singularities (1987) (8)
- CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies (2022) (7)
- ON A FINITENESS THEOREM ABOUT PROBLEMS INVOLVING INEQUALITIES (1994) (7)
- Rational Homotopy Type (1987) (7)
- A Retrospective Analysis of Cytogenetic and Clinical Characteristics in Patients With Multiple Myeloma (2013) (6)
- The characteristic set method and its applications (2000) (6)
- CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations (2020) (5)
- Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report (2019) (5)
- Candida tropicalis arthritis in a patient with acute leukemia. (2008) (5)
- Simplified MIPI-B prognostic stratification method can predict the outcome well—retrospective analysis of clinical characteristics and management of newly-diagnosed mantle cell lymphoma patients from China (2019) (5)
- Efficacy of CD19-targeted chimeric antigen receptor T cells in the treatment of relapsed extramedullary B-cell acute lymphoblastic leukemia (B-ALL) and diffuse large B-cell lymphoma (DLBCL). (2017) (4)
- Clinical implications of c-maf expression in plasma cells from patients with multiple myeloma (2017) (4)
- Efficacy of Intermittent, Oral Famciclovir Prophylaxis for Bortezomib-Induced Herpes Zoster in Multiple Myeloma Patients (2022) (4)
- Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway (2013) (4)
- Pleural cavity cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy (2018) (4)
- Idiopathic thrombocytopenic purpura treatment in a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T cell therapy (2020) (3)
- A Theorem on Immersion (1964) (3)
- Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report (2022) (3)
- THEORY OF I * -FUNCTOR IN ALGEBRAIC TOPOLOGY——REAL TOPOLOGY OF FIBER SQUARES (1975) (3)
- Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse (2021) (3)
- Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia (2021) (3)
- Topologie combinatoire et invariants combinatoires (1959) (2)
- Acute myeloid leukemia of a primary hepatic carcinoma patient after liver transplantation: a case report and literature review. (2015) (2)
- Vernodalol mediates antitumor effects in acute promyelocytic leukemia cells (2017) (2)
- Acute myeloid leukemia patient with FLT 3-ITD and NPM 1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR 1 for better prognosis (2019) (2)
- Quercetin Displays Anti-Myeloma Activity and Synergistic Effect with Dexamethasone in Vitro and In Vivo Xenograft Models (2015) (2)
- On a Finiteness Theorem about Optimization Problems (2008) (2)
- On the relations between Smith operations and Steenrod powers (1957) (2)
- Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy. (2017) (2)
- Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report (2019) (2)
- Automatic Geometry Theorem-Proving and Automatic Geometry Problem-Solving (1998) (2)
- Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy (2022) (1)
- On Algebrico-Differential Equations-Solving 1 ) (2003) (1)
- The Clinical Characteristics and Prognosis of Chinese Patients with Light-Chain Amyloidosis: A Retrospective Multicenter Analysis (2021) (1)
- On a finite kernel theorem for polynomial-type optimization problems and some of its applications (2005) (1)
- Chern classes on algebraic varieties with arbitrary singularities (1984) (1)
- The Char-Set Method and Its Applications to Automated Reasoning (1997) (1)
- Mechanical Derivation of Newton’s Gravitational Laws from Kepler’s Laws (2014) (1)
- Factors Associated with Durable Progression-Free Survival in Relapsed or Refractory Multiple Myeloma Patients after Potent Anti-BCMA CAR-T Cell Therapy (2021) (1)
- TET2 Downregulation Leads to AML Cells Sensitive to Decitabine (2015) (1)
- Effective computation and axiomatic system of I*-measure (1987) (1)
- The de rham-sullivan theorem and I*-measure (1987) (1)
- Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China (2021) (1)
- Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway (2018) (1)
- I*-measure and homotopy (1987) (1)
- Quantification of Non-Hodgkin Lymphoma Disease Burden Using FDG PET-CT Helps Predict the Severity of Cytokine Release Syndrome (2018) (1)
- I*-measure of a homogeneous space — The cartan theorem (1987) (1)
- Corrigendum to: Ginkgetin inhibits proliferation of human leukemia cells via the TNF-α signaling pathway (2017) (1)
- Oxymatrine Induces Apoptosis in Human Myeloma Cells By Cell Cycle Arrest and Activation of Caspase-Dependent Apoptosis (2014) (1)
- I*-measures connected with fibrations (1987) (1)
- Homoharringtonine In Combination With Cytarabine and Etoposide For Induction Therapy In Patients With De Novo Acute Myelogenous Leukemia (2013) (1)
- Interference of HMGB1 Lead to Increased Vulnerability of MM Cells to Dexamethasone and Doxorubicin (2016) (0)
- Retrospective analysis of Stenotrophomonas maltophilia bacteremia : clinical features , risk factors and therapeutic choices (2017) (0)
- Efficacy and Safety of Bortezomib Based Regimens Retreatment in Relapsed Multiple Myeloma Patients: Results from a Retrospective Study. (2015) (0)
- Donor Inflammatory Gene Polymorphisms Are Associated with Early Bacterial Infection After Unrelated Allogeneic Haematopoietic Stem Cell Transplantation. (2009) (0)
- Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report (2019) (0)
- Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL (2023) (0)
- HLA‐matched allogeneic anti‐CD19 CAR‐T therapy in treating a relapsed/refractory acute lymphoblastic leukemia patient with high tumor burden (2022) (0)
- Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients (2012) (0)
- The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma (2014) (0)
- [Inhibition effect of fludarabine on the growth of myelodysplastic syndrome cell line MUTZ-1 and its mechanism]. (2006) (0)
- Targeting HMGB1 Increased the Sensitivity of MM Cells to Chemotherapy (2014) (0)
- Candida tropicalis Arthritis of the Knee in a Patient with Acute Monocytic Leukemia. (2006) (0)
- A National, Multicenter, Retrospective Study of Castleman Disease Implementing Cdcn Criteria: 'severe Imcd' Is Indeed Severe (2022) (0)
- Bortezomib In Combination with Dexamethasone and Liposome- Adriamycin Chemotherapy Regimen for Relapsed and Refractory Hodgkin Lymphoma: A Case Report (2010) (0)
- Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy (2021) (0)
- Experience of Therapy for Pneumonia In Hematopoietic Stem Cell Transplant Recipients Infected by Influenza 2009 H1N1. (2010) (0)
- Anaplastic large cell lymphoma in undescended testis of a patient with 46 , XY disorder of sex development ( DSD ) : a case report (2018) (0)
- Preliminary Outcomes of Orelabrutinib Plus RCHOP in Treatment-Naïve Patients with Double-Expression Diffuse Large B Cell Lymphoma (2022) (0)
- Comparable Outcomes of Sibling and Unrelated Donors Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (2008) (0)
- A novel risk model for predicting early relapse in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem-cell transplantation. (2023) (0)
- Analysis of Clinical Characteristics and High-Risk Factors of Patients with Extramedullary Relapse Multiple Myeloma (2022) (0)
- Bortezomib-Resistance Is Characterized By Upregulation of E3 Ligase Pirh2 Which Protects Bortezomib Induced Apoptosis in Multiple Myeloma Cells (2014) (0)
- Donor Lymphocyte Infusion After Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies. (2010) (0)
- The efficacy of residual plerixafor for second-day stem cell mobilization in multiple myeloma patients. (2022) (0)
- Bortezomib-based regimens for primary multiple myeloma patients in China: from 2006 to 2018 (2019) (0)
- Clinical Significance of Serum Free Light Chain Test in the First Onset of Multiple Myeloma (2012) (0)
- Cytomegalovirus and Epstein-Barr virus infection during daratumumab treatment in patients with multiple myeloma (2022) (0)
- “Back-up” Stem Cell Harvest Is Beneficial for Patients Receiving Unrelated Donor Allogeneic Hematopoietic Cell Transplantation. (2010) (0)
- Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report (2019) (0)
- Retrospective analysis of cytogenetic and clinical characteristics on 65 patients with multiple myeloma (2011) (0)
- Gut microbiome modulates cytokine release syndrome and therapeutic response to CAR-T therapy in hematologic malignancies (2021) (0)
- Homoharringtonine Induced Apoptosis of Leukemic Cell Line MUTZ-1 Cells Is Mediated by the Endoplasmic Reticulum Stress Pathway. (2005) (0)
- Combination therapy based on bortezomib for 102 patients with newly-diagnosed multiple myeloma: a Chinese experience (2011) (0)
- Bortezomib in Combination with Dexamethasone and Subsequent Thalidomide for Newly-Diagnosed Multiple Myeloma in Chinese Patients. (2007) (0)
- Hematopoietic Score for the Prognostic Evaluation of Multiple Myeloma Patients Undergoing First-Line Treatment With A Bortezomib-Based Regimen (2020) (0)
- The Clinical Characteristics and Prognosis of Chinese Patients With Primary Light-Chain Amyloidosis: A Retrospective Multicenter Analysis (2019) (0)
- Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma (2017) (0)
- Combination Therapy Based on Bortezomib for Newly-Diagnosed Multiple Myeloma: a Chinese Experience (2010) (0)
- Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China (2021) (0)
- Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia (2018) (0)
- Proteasome Inhibitor or Immunomodulators Which is The Optimal Maintenance For Newly Diagnosed Multiple Myeloma: A 7-Year Real-World Data in China. (2021) (0)
- High Safety and Efficacy of CRISPR-Based Non-Viral PD-1 Locus Specific Integrated Anti-CD19 CAR-T Cells (BRL-201) in Treating Relapsed or Refractory Non-Hodgkin's Lymphoma: First-in-Human Phase I Study (2022) (0)
- Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia (2018) (0)
- The Expression Of CD200 As a Prognostic Factor In Newly Diagnosed Multiple Myeloma (2013) (0)
- Analysis of High-Risk Extramedullary Relapse Factors in Newly Diagnosed MM Patients (2022) (0)
- Macrophages promote DNA repair of double strand break in multiple myeloma cells by non-homologous end joining(NHEJ), nevertheless sacrifice the accuracy of NHEJ (2019) (0)
- Geometry Theorem Proving in Euclidean, Descartesian, Hilbertian and Computerwise Fashion (1996) (0)
- de Rham-Sullivan Measure of Spaces and Its Calculability (1980) (0)
- Euler Equations Related to the Generalized Neveu{Schwarz Algebra (2013) (0)
- NOTES ON COMPLEX MANIFOLDS AND ALGEBRAIC VARIETIES I. PLūCKER'S FORMULA (1962) (0)
- MAXIMAL FACTORS OF ORDER d OF DYNAMICAL CUBESPACES (2020) (0)
- Tropical Mirror (2022) (0)
- Seventeen Papers on Topology and Differential Geometry (1970) (0)
- Dga and minimal model (1987) (0)
- Fundamental concepts. Measure and calculability (1987) (0)
This paper list is powered by the following services:
Other Resources About Wu Wenjun
What Schools Are Affiliated With Wu Wenjun?
Wu Wenjun is affiliated with the following schools:
